Name
Considerations for Implementing Decentralized or Flexible Clinical Trials
Date & Time
Tuesday, October 12, 2021, 1:55 PM
Description
Charmaine Demanuele, Director, Early Clinical Development Biostatistics, Pfizer Inc.
Robert “Joe” Mather, Executive Director, Head of Advanced Sciences, Digital Medicine & Translational Imaging, Early Clinical Development, Pfizer Inc.